Sycamore House

Podcast: In 20 years cell and gene therapies for cancer will be commonplace

Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the

Kadans strengthens UK & Ireland team with Commercial Manager

Kadans Science Partner strengthens UK & Ireland team with appointment of  Commercial Manager Kadans Science Partner is delighted to announce the appointment of Katie Nelson, to strengthen its international team as a Commercial Manager

Kadans expands UK network with investment into Oxfordshire

Kadans Science Partner has added The Science Quadrant, Abingdon,  Oxford to its Pan-European science park portfolio. The asset was acquired from Addington Capital (PRA 2 S.A.R.L.). The Science Quadrant comprises four terraces of office

Kadans strengthens international team with appointment of Head of Commercial UK&I

Kadans Science Partner strengthens international team with appointment of Head of Commercial UK&I Kadans Science Partner is delighted to announce the appointment of James Sheppard, to strengthen its international team as the new Head

Kadans breidt uit met investering in research & development hub in Stevenage UK

Kadans breidt de aanwezigheid in het Verenigd Koninkrijk uit met de toevoeging van een tweede research hub aan haar Pan-Europese science park portefeuille. Kadans verwerft Sycamore House van GSK. Het betreft een industrieel pakhuis